A new government analysis revealed that despite a previous warning, CMS failed to take steps to ensure that Medicare Part D does not also pay for drugs that should be covered under the Part A hospice benefit; with studies of antidepressants’ safety and efficacy only following patients for a few years and with more people taking antidepressants for longer periods of time, health professionals are concerned that some people taking the drugs for extended periods shouldn’t be and are thus subjecting themselves to side effects and potential health risks; Medicaid advocates in Nebraska have filed a lawsuit to try and force the state to implement Medicaid expansion no later than November 17, 2019.
A new government analysis revealed that despite a previous warning, CMS failed to take steps to ensure that Medicare Part D does not also pay for drugs that should be covered under the Part A hospice benefit. This resulted in $161 million in duplicate payments in 2016. According to STAT News, duplicate payments were pointed out in 2009 by a 2012 report issued by HHS’ Office of the Inspector General (OIG). In the new analysis, the OIG found that Part D paid $422.7 million for 6.7 million prescriptions for beneficiaries who received hospice care. Hospice organizations should have paid for the drugs and hospices or beneficiaries should have paid for the remaining $262 million in Part D total cost.
With studies of antidepressants’ safety and efficacy only following patients for a few years and with more people taking antidepressants for longer periods of time, health professionals are concerned that some people taking the drugs for extended periods shouldn’t be and are thus subjecting themselves to side effects and potential health risks. According to The Wall Street Journal, some studies have suggested some serious potential risks, including one meta-analysis that found people who used antidepressants had a 14% higher risk of heart attacks and strokes and a 33% increased risk of death.
Medicaid advocates in Nebraska have filed a lawsuit to try and force the state to implement Medicaid expansion no later than November 17, 2019, reported The Hill. According to the lawsuit, the state will miss out on approximately $149 million in federal funding by delaying implementation until October 1, 2020. The suit also says that beginning expansion in November this year will allow federal funds to pay for 93% of the cost of expansion. Voters in the state approved a ballot measure last November that would expand coverage to approximately 94,000 residents in the state. State officials have said they need time to implement expansion methodically and that 2020 implementation would allow them to do so.
Prices for care at hospital trauma centers vary across hospitals; drug shortages reached a record high during the first quarter of 2024; although 3 of the biggest makers of asthma inhalers pledged to cap out-of-pocket costs for some US patients at $35, these do not apply to daily inhalers used by the youngest kids with asthma.
Read More
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More
Exploring Medicare Advantage Prior Authorization Variations
March 26th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the March 2024 issue of The American Journal of Managed Care® about their findings on variations in prior authorization use across Medicare Advantage plans.
Listen